Finch Therapeutics Group Net Tangible Assets

Finch Therapeutics Group (FNCH) currently reports a net tangible assets of $14M as of June 2024. That compares with $28M in the prior-year period — down 49.0% year over year. Use the charts on this page to explore Finch Therapeutics Group's net tangible assets history and peer comparisons.

Finch Therapeutics Group's net tangible assets decreased from $28M to $14M — a 49.0% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Finch Therapeutics Group reported $14M in net tangible assets as of June 2024. That compares with $28M in the prior-year period — down 49.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $14M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Finch Therapeutics Group, and consider following FNCH for alerts when major investors trade the stock.

Finch Therapeutics Group is classified in the Healthcare sector. On net tangible assets, it currently shows $14M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FNCH with unrelated industries.